bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide

C121H100F18N28O11S4 — CID 161420924

IUPACbis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide
SMILESCCc1ccc(-c2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2C)cc1.CNS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.CS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.Cc1c(Nc2ccc(OC(F)(F)F)cc2)ncnc1-n1ccnc1CCN1CCOCC1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1
InChIInChI=1S/2C22H15F3N6OS.C21H23F3N6O2.C20H18F3N3O.C18H15F3N4O3S.C18H14F3N3O3S/c2*23-22(24,25)32-17-4-2-16(3-5-17)30-21-8-19(26-12-27-21)15-9-29-31(11-15)10-14-1-6-18-20(7-14)33-13-28-18;1-15-19(28-16-2-4-17(5-3-16)32-21(22,23)24)26-14-27-20(15)30-9-7-25-18(30)6-8-29-10-12-31-13-11-29;1-3-14-4-6-15(7-5-14)18-13(2)19(25-12-24-18)26-16-8-10-17(11-9-16)27-20(21,22)23;1-22-29(26,27)15-8-2-12(3-9-15)16-10-17(24-11-23-16)25-13-4-6-14(7-5-13)28-18(19,20)21;1-28(25,26)15-8-2-12(3-9-15)16-10-17(23-11-22-16)24-13-4-6-14(7-5-13)27-18(19,20)21/h2*1-9,11-13H,10H2,(H,26,27,30);2-5,7,9,14H,6,8,10-13H2,1H3,(H,26,27,28);4-12H,3H2,1-2H3,(H,24,25,26);2-11,22H,1H3,(H,23,24,25);2-11H,1H3,(H,22,23,24)
InChIKeyVWSMGAQGNQXBAF-UHFFFAOYSA-N
MW2592.55 g/mol
LogP28.31
Rot. Bonds35

About bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide

bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide (PubChem CID 161420924) has the molecular formula C121H100F18N28O11S4 and a molecular weight of 2592.55 g/mol. Its IUPAC name is bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide.

Molecular Properties

Compound Namebis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide
PubChem CID161420924
Molecular FormulaC121H100F18N28O11S4
Molecular Weight2592.55 g/mol
Exact Mass2590.67
IUPAC Namebis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide
SMILESCCc1ccc(-c2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2C)cc1.CNS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.CS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.Cc1c(Nc2ccc(OC(F)(F)F)cc2)ncnc1-n1ccnc1CCN1CCOCC1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1
InChIInChI=1S/2C22H15F3N6OS.C21H23F3N6O2.C20H18F3N3O.C18H15F3N4O3S.C18H14F3N3O3S/c2*23-22(24,25)32-17-4-2-16(3-5-17)30-21-8-19(26-12-27-21)15-9-29-31(11-15)10-14-1-6-18-20(7-14)33-13-28-18;1-15-19(28-16-2-4-17(5-3-16)32-21(22,23)24)26-14-27-20(15)30-9-7-25-18(30)6-8-29-10-12-31-13-11-29;1-3-14-4-6-15(7-5-14)18-13(2)19(25-12-24-18)26-16-8-10-17(11-9-16)27-20(21,22)23;1-22-29(26,27)15-8-2-12(3-9-15)16-10-17(24-11-23-16)25-13-4-6-14(7-5-13)28-18(19,20)21;1-28(25,26)15-8-2-12(3-9-15)16-10-17(23-11-22-16)24-13-4-6-14(7-5-13)27-18(19,20)21/h2*1-9,11-13H,10H2,(H,26,27,30);2-5,7,9,14H,6,8,10-13H2,1H3,(H,26,27,28);4-12H,3H2,1-2H3,(H,24,25,26);2-11,22H,1H3,(H,23,24,25);2-11H,1H3,(H,22,23,24)
InChIKeyVWSMGAQGNQXBAF-UHFFFAOYSA-N
XLogP28.31
TPSA454.26 Ų
H-Bond Donors7
H-Bond Acceptors40
Rotatable Bonds35
Heavy Atoms182
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002592.55
LogP ≤ 528.31
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1040

Analyze bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide?
The IUPAC name of bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide (CID 161420924) is bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide.
What is the SMILES notation for bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide?
The canonical SMILES for bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide is CCc1ccc(-c2ncnc(Nc3ccc(OC(F)(F)F)cc3)c2C)cc1.CNS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.CS(=O)(=O)c1ccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)cc1.Cc1c(Nc2ccc(OC(F)(F)F)cc2)ncnc1-n1ccnc1CCN1CCOCC1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1.FC(F)(F)Oc1ccc(Nc2cc(-c3cnn(Cc4ccc5ncsc5c4)c3)ncn2)cc1.
What is the InChIKey of bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide?
The InChIKey is VWSMGAQGNQXBAF-UHFFFAOYSA-N. The full InChI is InChI=1S/2C22H15F3N6OS.C21H23F3N6O2.C20H18F3N3O.C18H15F3N4O3S.C18H14F3N3O3S/c2*23-22(24,25)32-17-4-2-16(3-5-17)30-21-8-19(26-12-27-21)15-9-29-31(11-15)10-14-1-6-18-20(7-14)33-13-28-18;1-15-19(28-16-2-4-17(5-3-16)32-21(22,23)24)26-14-27-20(15)30-9-7-25-18(30)6-8-29-10-12-31-13-11-29;1-3-14-4-6-15(7-5-14)18-13(2)19(25-12-24-18)26-16-8-10-17(11-9-16)27-20(21,22)23;1-22-29(26,27)15-8-2-12(3-9-15)16-10-17(24-11-23-16)25-13-4-6-14(7-5-13)28-18(19,20)21;1-28(25,26)15-8-2-12(3-9-15)16-10-17(23-11-22-16)24-13-4-6-14(7-5-13)27-18(19,20)21/h2*1-9,11-13H,10H2,(H,26,27,30);2-5,7,9,14H,6,8,10-13H2,1H3,(H,26,27,28);4-12H,3H2,1-2H3,(H,24,25,26);2-11,22H,1H3,(H,23,24,25);2-11H,1H3,(H,22,23,24).
What are the key properties of bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide?
bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide has a molecular weight of 2592.55 g/mol, XLogP of 28.31, 35 rotatable bonds, 7 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for bis(6-[1-(1,3-benzothiazol-6-ylmethyl)pyrazol-4-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine);6-(4-ethylphenyl)-5-methyl-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;5-methyl-6-[2-(2-morpholin-4-ylethyl)imidazol-1-yl]-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;6-(4-methylsulfonylphenyl)-N-[4-(trifluoromethoxy)phenyl]pyrimidin-4-amine;N-methyl-4-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzenesulfonamide is sourced from PubChem (CID 161420924), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).